HUMA
Humacyte, Inc. · Healthcare
Director Brady W Dougan sold $7.8M of Humacyte, Inc.
Sold$7,832,200
$7.82Price
1,001,852Shares
−12%Stake
What HUMA did after the filing
- The stock from Wed, Jun 5 open, $6.65
- +13.5%
- S&P 500, same days
- +3.8%
Measured over 30 trading days, to the Jul 19 close.
Traded Fri, May 31. Filed Tue, Jun 4. Returns use the Jun 5 open and the Jul 19 close. Not investment advice.